🇺🇸 FDA
Patent

US 10722537

Activation of resident memory T cells for cancer immunotherapy

granted A61KA61K2039/585A61K2239/31

Quick answer

US patent 10722537 (Activation of resident memory T cells for cancer immunotherapy) held by Regents of the University of Minnesota expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
53
CPC classes
A61K, A61K2039/585, A61K2239/31, A61K2239/38, A61K2239/57